- Home
- GFF vs VCYT Comparison
GFF vs VCYT Comparison
Compare GFF & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFF
- VCYT
- Stock Information
- Founded
- GFF 1959
- VCYT 2006
- Country
- GFF United States
- VCYT United States
- Employees
- GFF N/A
- VCYT N/A
- Industry
- GFF Building Products
- VCYT Medical Specialities
- Sector
- GFF Industrials
- VCYT Health Care
- Exchange
- GFF Nasdaq
- VCYT Nasdaq
- Market Cap
- GFF 3.6B
- VCYT 3.2B
- IPO Year
- GFF N/A
- VCYT 2013
- Fundamental
- Price
- GFF $77.53
- VCYT $43.31
- Analyst Decision
- GFF Strong Buy
- VCYT Buy
- Analyst Count
- GFF 4
- VCYT 7
- Target Price
- GFF $89.25
- VCYT $39.86
- AVG Volume (30 Days)
- GFF 393.8K
- VCYT 783.4K
- Earning Date
- GFF 02-05-2025
- VCYT 02-20-2025
- Dividend Yield
- GFF 0.91%
- VCYT N/A
- EPS Growth
- GFF 197.89
- VCYT N/A
- EPS
- GFF 4.23
- VCYT N/A
- Revenue
- GFF $2,623,520,000.00
- VCYT $425,331,000.00
- Revenue This Year
- GFF $0.93
- VCYT $25.25
- Revenue Next Year
- GFF $3.10
- VCYT $9.99
- P/E Ratio
- GFF $18.61
- VCYT N/A
- Revenue Growth
- GFF N/A
- VCYT 23.95
- 52 Week Low
- GFF $55.01
- VCYT $18.61
- 52 Week High
- GFF $86.73
- VCYT $46.00
- Technical
- Relative Strength Index (RSI)
- GFF 63.07
- VCYT 58.96
- Support Level
- GFF $74.87
- VCYT $40.29
- Resistance Level
- GFF $78.86
- VCYT $43.53
- Average True Range (ATR)
- GFF 1.73
- VCYT 1.88
- MACD
- GFF 0.85
- VCYT 0.12
- Stochastic Oscillator
- GFF 95.49
- VCYT 93.95
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products and Home and Building Products. The company generates a majority of its revenue from the Home and Building Products segment.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.